The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Terumo’s Misago Stent to Be Jointly Studied in US and Japan

May 12, 2010—Terumo Medical Corporation (Somerset, NJ) announced it has received an investigational device exemption conditional approval from the US Food and Drug Administr…

Interim 2-Year SFA Data Presented for Cook’s Zilver PTX Stent

May 7, 2010—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of interim results showing that patients with peripheral artery …

Two-Year SFA Data Presented for Cook’s Zilver PTX Stent

CONFERENCE COVERAGE

May 7, 2010—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of interim results showing that patients with peripheral artery…

Patient Enrollment Completed in DURABILITY II Study of ev3’s EverFlex

April 26, 2010—ev3 Inc. (Plymouth, MN) announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multicenter, single-arm study evaluating the…

An Interview With Lawrence A. Garcia, MD

April 2010—With many treatment choices available for SFA disease, Dr. Garcia shares how he determines which therapy is right for each patient, as well as his current research endeavors.

Enrollment Completed in STROLL Study of Cordis's SMART Stent to Treat SFA Disease

March 20, 2010—Cordis Corporation (Bridgewater, NJ) announced the completion of patient enrollment in the STROLL (SMART Nitinol Self-Expandable Stent in the Treatment of Obs…

CHIEF MEDICAL EDITOR’S PAGE: The Long and Winding Road

John R. Laird Jr, MD

March 2010—For several years now, we have seen the arsenal of techniques used to treat superficial femoral artery (SFA) disease continually expand. New classes of devices have emerged…

Drug-Eluting Balloons in the SFA

March 2010—Dierk Scheinert, MD, discusses the THUNDER and FemPac trial results and previews new studies that will evaluate drug-coated balloons versus plain old balloon angioplasty.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.